Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-08-02
2011-08-02
Audet, Maury (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S001690
Reexamination Certificate
active
07989414
ABSTRACT:
The present invention relates to blood products, and more particularly to compositions comprising a modified oxygenated hemoglobin having a high affinity for oxygen and methods for making such compositions. Such compositions according to the present invention have better stability to autooxidation and superior oxygen carrying characteristics.
REFERENCES:
patent: 3518982 (1970-07-01), Timmins et al.
patent: 3925344 (1975-12-01), Mazur
patent: 3956259 (1976-05-01), Garcia et al.
patent: 4001200 (1977-01-01), Bonsen et al.
patent: 4001401 (1977-01-01), Bonsen et al.
patent: 4053590 (1977-10-01), Bonsen et al.
patent: 4061736 (1977-12-01), Morris et al.
patent: 4064118 (1977-12-01), Wong
patent: 4113853 (1978-09-01), Funakoshi et al.
patent: 4133874 (1979-01-01), Miller et al.
patent: 4179337 (1979-12-01), Davis et al.
patent: 4209300 (1980-06-01), Thibault
patent: 4301144 (1981-11-01), Iwashita et al.
patent: 4336248 (1982-06-01), Bonhard et al.
patent: 4377512 (1983-03-01), Ajisaka et al.
patent: 4401652 (1983-08-01), Simmonds et al.
patent: 4412989 (1983-11-01), Iwashita et al.
patent: 4439357 (1984-03-01), Bonhard et al.
patent: 4473494 (1984-09-01), Tye
patent: 4473496 (1984-09-01), Scannon
patent: 4526715 (1985-07-01), Kothe et al.
patent: 4529719 (1985-07-01), Tye
patent: 4532130 (1985-07-01), Djordjevich et al.
patent: 4584130 (1986-04-01), Bocci et al.
patent: 4598064 (1986-07-01), Walder
patent: 4600531 (1986-07-01), Walder
patent: 4650786 (1987-03-01), Wong
patent: 4670417 (1987-06-01), Iwasaki et al.
patent: 4710488 (1987-12-01), Wong
patent: 4738952 (1988-04-01), Ecanow et al.
patent: 4777244 (1988-10-01), Bonhard et al.
patent: 4826811 (1989-05-01), Sehgal et al.
patent: 4831012 (1989-05-01), Estep
patent: 4857636 (1989-08-01), Hsia
patent: 4861867 (1989-08-01), Estep
patent: 4900780 (1990-02-01), Cerny
patent: 4911929 (1990-03-01), Farmer et al.
patent: 4920194 (1990-04-01), Feller et al.
patent: 4987154 (1991-01-01), Long
patent: 5028588 (1991-07-01), Hoffman et al.
patent: 5041615 (1991-08-01), Hai et al.
patent: 5058416 (1991-10-01), Engelhardt et al.
patent: 5061688 (1991-10-01), Beissinger et al.
patent: 5077036 (1991-12-01), Long
patent: 5080885 (1992-01-01), Long
patent: 5084558 (1992-01-01), Rausch
patent: 5114932 (1992-05-01), Runge
patent: 5115100 (1992-05-01), Wu et al.
patent: 5128452 (1992-07-01), Hai et al.
patent: 5194590 (1993-03-01), Sehgal et al.
patent: 5200323 (1993-04-01), Chang et al.
patent: 5217648 (1993-06-01), Beissinger et al.
patent: 5234903 (1993-08-01), Nho et al.
patent: 5239061 (1993-08-01), Fronticelli et al.
patent: 5248766 (1993-09-01), Nelson et al.
patent: 5250665 (1993-10-01), Kluger et al.
patent: 5264555 (1993-11-01), Shorr et al.
patent: 5281579 (1994-01-01), Estep
patent: 5295944 (1994-03-01), Teicher et al.
patent: 5296465 (1994-03-01), Rausch et al.
patent: 5312808 (1994-05-01), Shorr et al.
patent: 5334705 (1994-08-01), Bonaventura et al.
patent: 5334706 (1994-08-01), Przybelski
patent: 5344393 (1994-09-01), Roth et al.
patent: 5349054 (1994-09-01), Bonaventura et al.
patent: 5352773 (1994-10-01), Kandler et al.
patent: 5386014 (1995-01-01), Nho et al.
patent: 5407428 (1995-04-01), Segall et al.
patent: 5438041 (1995-08-01), Zheng et al.
patent: 5439591 (1995-08-01), Pliura et al.
patent: 5449759 (1995-09-01), Hoffman et al.
patent: 5451205 (1995-09-01), Roth et al.
patent: 5464814 (1995-11-01), Sehgal et al.
patent: 5478805 (1995-12-01), Shorr et al.
patent: 5478806 (1995-12-01), Nho
patent: 5480866 (1996-01-01), Bonaventura et al.
patent: 5510464 (1996-04-01), Przybelski
patent: 5525630 (1996-06-01), Hoffman
patent: 5532352 (1996-07-01), Pliura et al.
patent: 5545328 (1996-08-01), Pliura et al.
patent: 5545727 (1996-08-01), Hoffman et al.
patent: 5554638 (1996-09-01), Dewhirst et al.
patent: 5563254 (1996-10-01), Hoffman et al.
patent: 5571801 (1996-11-01), Segall et al.
patent: 5574019 (1996-11-01), Segall et al.
patent: 5578564 (1996-11-01), Chivers et al.
patent: 5585484 (1996-12-01), Acharya et al.
patent: 5591710 (1997-01-01), Hsia
patent: 5595723 (1997-01-01), Quay
patent: 5599907 (1997-02-01), Anderson et al.
patent: 5612310 (1997-03-01), Dewhirst et al.
patent: 5613944 (1997-03-01), Segall et al.
patent: 5614490 (1997-03-01), Przybelski
patent: 5618919 (1997-04-01), Rausch et al.
patent: 5628930 (1997-05-01), Weers et al.
patent: 5631219 (1997-05-01), Rosenthal et al.
patent: 5635538 (1997-06-01), Weers et al.
patent: 5635539 (1997-06-01), Clark et al.
patent: 5650388 (1997-07-01), Shorr et al.
patent: 5661124 (1997-08-01), Hoffman et al.
patent: 5814601 (1998-09-01), Winslow et al.
patent: 5985825 (1999-11-01), Winslow et al.
patent: 6054427 (2000-04-01), Winslow
patent: 6269679 (2001-08-01), McCarthy et al.
patent: 6432918 (2002-08-01), Winslow
patent: 6500930 (2002-12-01), Adamson
patent: 6844317 (2005-01-01), Winslow et al.
patent: 6974795 (2005-12-01), Winslow et al.
patent: 7625862 (2009-12-01), Winslow et al.
patent: 2004/0072729 (2004-04-01), Kwang et al.
patent: 2430898 (1976-01-01), None
patent: 0340908 (1989-08-01), None
patent: 0361719 (1990-04-01), None
patent: 0478048 (1992-04-01), None
patent: 02124445 (1990-05-01), None
patent: WO 87/07832 (1987-12-01), None
patent: WO 90/13309 (1990-11-01), None
patent: WO 91/07190 (1991-05-01), None
patent: WO 98/37909 (1998-09-01), None
Ajisaka, Katsumi et al., “Modification of Human Hemoglobin with Polyethylene Glycol: A New Candidate for Blood Substitute”,Biochem. Biophys. Res. Comm., 97(3)1076-1081 (Dec. 1980).
Amberson, “Clinical Experience with Hemoglobin-Saline Solutions”,Science, 106:117 (1947).
Ampulski et al, “Determination of the Reactive Sulfhydryl Groups in Heme Proteins with 4, 4′-dipyridinesdisulde”,Biochem. Biophys. Acta., 163-169 (1969).
Blumenstein et al., “Experimental Transfusion of Dextran-Hemoglobin”, InBlood Substitutes and Plasma Expanders, (Liss, Ed.) New York, NY pp. 205-212 (1978).
Brantley et al., “The Mechanism of Autooxidation of Myoglobin”,Journal of Biological Chemistry, 268(10):6995-7010 (1992).
Doherty et al., “Rate of Reaction with Nitric Oxide Determines the Hypertensive Effect of Cell-Free Hemoglobin”,Nature Biotechnology, 16:672-676 (1998).
Guyton,Human Physiology and Mechanisms of Disease(3rdEd.) W.B. Saunders Co., Philadelphia, PA, pp. 228-229 (1982).
Hannon et al., “Blood Gas and Acid-Base Status of Conscious Pigs Subjected to Fixed-Volume Hemorrhage and Resuscitated with Hypertonic Sali Dextran”,Circ. Shock32:19-29 (1990).
Hess et al., “Pulmonary and Systemic Hypertension After Hemoglobin Administration”,Blood, 78:356A (1991).
Iwasaki et al., “Preparation and Evaluation of Hemoglobin-Polyethylene Glycol Conjugate (Pyridoxalated Polyethylene Glycol Hemoglobin) as an Oxygen-Carrying Resuscitation Fluid”,Artificial Organs10(5):411-416 (1986).
Kavdia et al., “Theoretical Analysis of Effects of Blood Substitute Affinity and Cooperativity on Organ Oxygen Transport”,J. Appl. Physiol. 93(6):2122-2128 (Dec. 2002).
Keipert et al., “Acute Changes in Systemic Blood Pressure and Urine Output of Conscious Rats Following Exchange Transfusion with Diaspirin-Crosslinked Hemoglobin Solution”,Transfusion33:701-708 (1993).
Lemon et al., “Control of the Nitric Oxide-Scavenging Activity of Hemoglobin”,Art. Cells Blood Subs., and Immob. Biotech. 24:378 (1996).
Liebhaber et al., “Cloning and Complete Nucleotide Sequence of Human 5′ -α-globin Gene” PNAS 77:7054-7058 (1980).
Lindbom et al., “Influence of Oxygen on Perfusion Capillary Density and Capillary Red Cell Velocity in Rabbit Skeletal Muscle”,Microvasc. Res. 19:197-208 (1980).
Marotta et al., “Human β-Globin Messenger RNA”,J. Biol. Chem. 353:5040-5053 (1977).
McCarthy et al., “The Role of Facilitated Diffusion in Oxygen Transport by Cell-free Hemoglobin: Implications for the Design of Hemoglobin-Based Oxygen Carriers”,Biophysical Chemistry92:
Vandegriff Kim D.
Winslow Robert M.
Audet Maury
Axford Laurie A.
Sangart, Inc.
The Nath Law Group
LandOfFree
Compositions for oxygen transport comprising a high oxygen... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions for oxygen transport comprising a high oxygen..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for oxygen transport comprising a high oxygen... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2671586